AS

Alex Santhosh

Active Director Managing Director DIN 11110182
DIN 11110182 First appointment May 2025
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Alex Santhosh

Data last updated:

Alex Santhosh is a Managing Director at Letzchem Healthcare Private Limited (since 2025).

DIN 11110182
Primary Designation Managing Director
First Appointment 16 May 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Letzchem Healthcare Private Limited U20230KL2025PTC094462
Managing Director16 May 20252025Active

Board colleagues of Alex Santhosh

NameDINCompanyDesignation
Eby Kuriakose11110181Letzchem Healthcare Private LimitedManaging Director
Eldo Kuriakose09832780Letzchem Healthcare Private LimitedManaging Director

Directorship timeline

Open interactive timeline →
Letzchem Healthcare Private Limited
Premium access

Shareholding and investment profile for Alex Santhosh

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Alex Santhosh

Alex Santhosh currently holds 1 directorship: Letzchem Healthcare Private Limited (Managing Director, since 16 May 2025).

Alex Santhosh was first appointed on 16 May 2025 as Managing Director at Letzchem Healthcare Private Limited.

The current boards of Alex Santhosh's companies include Eby Kuriakose (Letzchem Healthcare Private Limited), Eldo Kuriakose (Letzchem Healthcare Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available